Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-05 4:34 pm Purchase | 13D | TITAN PHARMACEUTICALS INC DEL TTNP | Sire Group Ltd. | 150,087 14.1% | 150,087 (New Position) | View |
| 2023-10-04 5:30 pm Purchase | 13D | TITAN PHARMACEUTICALS INC DEL TTNP | Sire Group Ltd. | 3,001,757 16.7% | 3,001,757 (New Position) | View |
| 2023-07-20 9:57 pm Purchase | 13D | TITAN PHARMACEUTICALS INC DEL TTNP | Choong Choon Hau | 3,747,968 24.95% | 3,747,968 (New Position) | View |
| 2023-06-23 4:05 pm Sale | 13D | TITAN PHARMACEUTICALS INC DEL TTNP | Activist Investing LLC | 0 0% | -3,690,468 (Position Closed) | View |
| 2022-12-15 08:10 am Unchanged | 13D | TITAN PHARMACEUTICALS INC DEL TTNP | Activist Investing LLC | 3,690,468 25.2% | 0 (Unchanged) | View |
| 2022-08-17 4:00 pm Unchanged | 13D | TITAN PHARMACEUTICALS INC DEL TTNP | Activist Investing LLC | 3,690,468 25.2% | 0 (Unchanged) | View |
| 2022-07-08 10:38 am Purchase | 13D | TITAN PHARMACEUTICALS INC DEL TTNP | Activist Investing LLC | 3,690,468 25.2% | 2,249,190 (+156.06%) | View |
| 2022-06-09 2:38 pm Purchase | 13D | TITAN PHARMACEUTICALS INC DEL TTNP | Activist Investing LLC | 1,441,278 9.9% | 768,067 (+114.09%) | View |
| 2022-04-25 2:55 pm Purchase | 13D | TITAN PHARMACEUTICALS INC DEL TTNP | Activist Investing LLC | 673,211 5.6% | 673,211 (New Position) | View |
| 2022-02-11 5:48 pm Sale | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | L1 Capital Global Opportunities Master Fund Ltd. | 494,716 4.99% | -186,534 (-27.38%) | View |
| 2022-01-24 10:35 am Sale | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | Empery Asset Management LP | 860,448 4.99% | -84,126 (-8.91%) | View |
| 2022-01-03 4:43 pm Sale | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | SABBY MANAGEMENT LLC | 494,716 11% | -186,534 (-27.38%) | View |
| 2021-01-25 08:26 am Sale | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | L1 Capital Global Opportunities Master Fund Ltd. | 681,250 6.9% | -9,038,750 (-92.99%) | View |
| 2021-01-22 11:58 am Purchase | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | SABBY MANAGEMENT LLC | 681,250 11% | 453,698 (+199.38%) | View |
| 2021-01-21 2:28 pm Purchase | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | Empery Asset Management LP | 944,574 6.91% | 944,574 (New Position) | View |
| 2021-01-07 10:00 am Purchase | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | SABBY MANAGEMENT LLC | 227,552 11% | 227,552 (New Position) | View |
| 2020-11-09 06:04 am Purchase | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | INTRACOASTAL CAPITAL LLC | 3,333 0.001% | 3,333 (New Position) | View |
| 2020-10-01 4:41 pm Purchase | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | L1 Capital Global Opportunities Master Fund Ltd. | 9,720,000 8.3% | 9,720,000 (New Position) | View |
| 2020-09-24 09:44 am Purchase | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | SABBY MANAGEMENT LLC | 9,720,000 11% | 6,397,718 (+192.57%) | View |
| 2020-01-27 11:33 am Purchase | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | Empery Asset Management LP | 7,922,395 4.99% | 4,589,062 (+137.67%) | View |